REDWOOD-HCM: Randomized Evaluation of Dosing With CK-3773274 in Obstructive Outflow Disease in HCM
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study is being performed to understand the effect of different doses of CK-3773274 on
patients with obstructive hypertrophic cardiomyopathy (oHCM).